Emily B. Schroeder, MD, PhD; Andrew J. Karter, PhD
Grant Support: Dr. Schroeder is supported by grants K23 DK099237 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and R01 HS022963 from the Agency for Healthcare Research and Quality. Dr. Karter is supported by grants P30 DK092924 and R01 DK103721 from NIDDK, R56 AG051683 from the National Institute on Aging, R01 LM012355 from the National Library of Medicine, and BAA-13-00119 from the U.S. Food and Drug Administration.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1471.
Corresponding Author: Emily B. Schroeder, MD, PhD, Institute for Health Research, Kaiser Permanente Colorado, 2550 South Parker Road, Suite 200, Aurora, CO 80014; e-mail, emily.b.schroeder@kp.org.
Current Author Addresses: Dr. Schroeder: Institute for Health Research, Kaiser Permanente Colorado, 2550 South Parker Road, Suite 200, Aurora, CO 80014.
Dr. Karter: Division of Research, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612.
Author Contributions: Conception and design: E.B. Schroeder.
Drafting of the article: E.B. Schroeder.
Critical revision for important intellectual content: E.B. Schroeder, A.J. Karter.
Final approval of the article: E.B. Schroeder, A.J. Karter.
Schroeder EB, Karter AJ. Brief Commentary: Glycemic Targets for Older Adults With Type 2 Diabetes. Ann Intern Med. ;169:250–251. doi: 10.7326/M18-1471
Download citation file:
© 2019
Published: Ann Intern Med. 2018;169(4):250-251.
DOI: 10.7326/M18-1471
Published at www.annals.org on 26 June 2018
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Geriatric Medicine.
Results provided by: